Andy Jassy’s annual shareholder letter reads something like a diss track to a wide range of competitors as he defends spending $200 billion in capex.
Source: TechCrunch
News Aggregation on Steroids
Andy Jassy’s annual shareholder letter reads something like a diss track to a wide range of competitors as he defends spending $200 billion in capex.
Source: TechCrunch